Latest Going Concern Risk News

Vitasora Health reported a sharp rise in losses and operating cash outflows for FY2025, despite achieving significant cost savings from its Orb Health acquisition. The company faces a material uncertainty over its ability to continue as a going concern.

Lumos Diagnostics reported an 11.4% revenue increase to US$12.4 million for FY2025, yet still posted a significant net loss amid auditor concerns over its future viability.

CurveBeam AI Limited posted a strong 85% increase in revenue to $12.1 million for FY25, alongside a reduced net loss of $16.8 million. Despite operational improvements and a recent $11.58 million capital raise, the company flags material uncertainty over its ability to continue as a going concern.

Way2VAT Ltd reported a 43% revenue increase to AUD 2.49 million in H1 FY25, driven by new enterprise contracts including a major deal with JLL. Despite improved operating losses and successful fundraising, the company faces ongoing net losses and liquidity concerns.

Imagion Biosystems reported a $1.66 million loss for the half-year ending June 2025 while progressing its MagSense® HER2 Imaging Agent towards a Phase 2 FDA trial and securing $3.5 million in new funding.

Enlitic, Inc. reported a sharp revenue increase driven by migration services and subscription growth, while sustaining a net loss of US$6.86 million in H1 2025. The company secured a binding MOU with GE Healthcare and completed a A$10 million capital raise.

Noumi Limited has posted a significant $150 million loss for the year ending June 2025, driven by non-cash charges and raising questions about its financial stability.

NOVONIX Limited reports progress scaling its Chattanooga synthetic graphite plant, secures major funding, and benefits from U.S. tariffs on Chinese imports, while narrowing its half-year loss.

Sarama Resources Ltd reported a $1.22 million net loss for the first half of 2025, while completing a $2.7 million equity placement and acquiring a majority stake in the Mt Venn Gold Project in Western Australia.

Red Mountain Mining Ltd has announced a pro-rata non-renounceable entitlement issue of RMXO Options priced at $0.001 each, aiming to raise up to $193,499 to support its working capital needs. The offer, exercisable at $0.02 until May 2027, carries notable risks including dilution and going concern uncertainties.

Euro Manganese Inc. reported a $12.8 million loss for the nine months ended June 30, 2025, while securing $11.1 million in equity financing and amending its $20 million convertible loan facility. The company highlights ongoing funding risks as it advances its manganese projects.

Metro Performance Glass proposes a $15–24 million recapitalisation involving a discounted rights offer and a major placement to Amari Metals, who would become the controlling shareholder.